fbpx
QQQ
-0.22
284.63
-0.08%
DIA
-1.04
284.05
-0.37%
SPY
-0.65
343.95
-0.19%
TLT
-0.55
159.80
-0.35%
GLD
+ 1.40
177.86
+ 0.78%

Where Will Tilray's Stock Find Technical Support?

April 4, 2019 3:16 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

While most cannabis stocks have had huge rallies so far in 2019, Tilray Inc (NASDAQ:TLRY) has been left in the dust. Aurora Cannabis Inc (NYSE:ACB), Aphria Inc (NYSE:APHA) and GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) are all up more than 65 percent year to date, while Tilray is down 12.5 percent in 2019.

Tilray bulls received more bad news this week, with the stock dipping to new 2019 lows. Here’s a look at what the charts are saying about Tilray’s technical picture and where the stock may finally find support.

Near-Term Breakdown

Unfortunately for Tilray bulls, the stock lost a major potential technical support level in recent weeks. Tilray bounced off the $64 level in both December and early March, giving bulls hope the stock had finally found support. Unfortunately, Tilray broke below $64 on April 1 and hasn’t made it back above that level since.

To make matters worse, the Tilray breakdown was part of a bearish descending triangle pattern that has been months in the making. A descending triangle is formed when a stock has a negatively sloped resistance line pinching a horizontal support line. Ultimately, the resistance line typically pushes the stock below its support level, which is what happened to Tilray this week.

Once a descending triangle breakdown occurs, the previous support level ($64) transitions to resistance, suggesting it will be difficult for Tilray to make it back above $64 in the near term.

The Cannabis Capital Conference is coming back to Toronto! Click here to learn how you can join Tim Seymour, Jon Najarian, Alan Brochstein and many others.

Long-Term Downside

Tilray doesn’t have a long history on the U.S. market to generate a longer-term technical picture, but there’s one glaring technical problem that stocks out like a sore thumb in the stock’s one-year chart. Tilray first listed on the Nasdaq last year at around $23 per share. It quickly got caught up in the cannabis stock market hype, which drove shares as high as $300 in intraday trading in September of last year.

Unfortunately, the stock’s meteoric rise happened so fast that it made a jump from around $45 to above $50 in late August and never looked back. This big jump left a gap in Tilray’s chart that was never filled, and technical traders know these gaps rarely stay open indefinitely. To close the gap, Tilray shares would need to trade down to around $45, roughly 26 percent additional downside from Thursday’s trading level.

Key Levels To Watch

The near-term technical good news for Tilray traders is that the stock’s recent breakdown has pushed its RSI into oversold territory at 28.3. That low RSI means Tilray shares could bounce a bit next week.

One key level traders need to watch is $64. Unless the stock closes above $64 and stays there, there’s very little to like about it from a technical perspective.

On the downside, there’s not much to like in terms of support until Tilray gets to $45. If the stock does bounce next week, wherever it bottoms will be the only potential near-term support level, but it’s unlikely to hold in the medium term.

The stock traded around $61.20 per share at time of publication.

Related Links:

2 Key Technical Levels Tesla Investors Should Keep An Eye On

Biotech Stock Applied DNA Sciences Jumps 50% On Cannabis Deal


Related Articles

US Election Could Have 'Positive Collateral Benefits' For Canadian Cannabis Stocks

Cannabis stocks got off to a hit start to the week following a CNBC story published over the weekend suggesting that a Joe Biden victory in the November election could open the door for the decriminalization of adult-use marijuana, potential rescheduling and other federal cannabis l read more

The Week In Cannabis: Aphria Earnings, Canopy's Distribution Deal, And A Big Conference

This was an exciting week for the cannabis industry, marked by the ninth edition of the Benzinga Cannabis Capital Conference. Benzinga’s last big cannabis event of 2020 took place virtually, featuring almost 100 speakers from all around the world. Read some of the key takeaways: read more

Mexico's Cannabis Legalization Addresses Several National Woes, Creates Opportunity

After several extended deadline extensions, Mexican lawmakers seem on course to legalize adult-use cannabis in the coming weeks. read more

Cannabis Analyst Talks Canadian Price Deflation, Names Aphria Top Stock Pick

The growth thesis for Canadian cannabis stocks certainly hasn’t played out the way investors had hoped in 2020. One of the biggest headwinds legal producers have faced this year is extreme price deflation in the Canadian market. Flower Prices Falling: Canadian flower prices are down 33% since mid-2019, according to Cantor Fitzgerald analyst Pablo Zuanic. read more

Analyst Previews Cannabis Earnings: Green Thumb Positioned To Beat By Hefty Margin

Cannabis stocks have been on fire since Kamala Harris said Democratic presidential candidate Joe Bid read more